PLSE — Pulse Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Pulse Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20.5	28.6	61.1	44.4	118
Net Total Accounts Receivable
Net Total Receivables	—	0.061	0	—	—
Total Inventory
Prepaid Expenses
Total Current Assets	22.3	36.6	62.1	45.3	119
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.9	11.2	10	8.78	8.32
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	41.3	54.2	77.9	59.2	132
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.58	8.52	5.98	6.71	10.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	18.4	18.6	80.1	14.8	17.6
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	22.9	35.7	-2.25	44.4	115
Total Liabilities & Shareholders' Equity	41.3	54.2	77.9	59.2	132
Total Common Shares Outstanding